Complement C1QC As a Potential Prognostic Marker and Therapeutic Target in Colon Carcinoma Based on Single-Cell RNA Sequencing and Immunohistochemical Analysis. Biomol Biomed 2022, 22 (6), 912-922. https://doi.org/10.17305/bjbms.2022.7309.